MNK - Wells Fargo likes Molina after Investor Day May, 31 2019 08:41 AM Mallinckrodt plc Allogene Therapeutics (NASDAQ:ALLO) initiated with Neutral rating at Guggenheim.More news on: Allogene Therapeutics, Inc., Fate Therapeutics, Inc., Rubius Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...